These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3524974

  • 1. [Sulodexide in the therapy of vasculopathies].
    Postiglione F, Pisani P, Gisonni P, Perrotta P, Gisonni A, Canciello M, Napolitano L, Brighina G, Ragno I, Salzano A.
    Clin Ter; 1986 May 15; 117(3):223-31. PubMed ID: 3524974
    [No Abstract] [Full Text] [Related]

  • 2. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
    Capone-Braga M, Tellini L, Boncompagni L, Bettoni M, Burali A, Bensi A.
    Clin Ter; 1987 Jan 15; 120(1):25-31. PubMed ID: 2973852
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
    Castello S.
    Clin Ter; 1971 Aug 31; 58(4):323-34. PubMed ID: 4258171
    [No Abstract] [Full Text] [Related]

  • 4. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G, Fellin R, Calabrò A, Baiocchi MR, Rossi A, Lenzi S, Descovich GC, Delmonte G, Gaddi A, Ventura A.
    Monogr Atheroscler; 1986 Aug 31; 14():215-21. PubMed ID: 3526129
    [No Abstract] [Full Text] [Related]

  • 5. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R, Violi G.
    Minerva Med; 1974 Nov 21; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R, Caliandro L, Cocchi A, Volpi F, Brusaioli G, Grignani G, Antognetti R.
    Clin Ter; 1975 May 15; 73(3):213-36. PubMed ID: 123842
    [No Abstract] [Full Text] [Related]

  • 7. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
    Ciammaichella A, Solitro A, Torcia L, Arcuri P.
    Clin Ter; 1978 Mar 15; 84(5):509-21. PubMed ID: 648104
    [No Abstract] [Full Text] [Related]

  • 8. Therapy and clinical trials.
    Curr Opin Lipidol; 1995 Dec 15; 6(6):B77-82. PubMed ID: 8750254
    [No Abstract] [Full Text] [Related]

  • 9. Lipids and their role in coronary heart disease: what they do and how to manage them.
    Pradka LR.
    Nurs Clin North Am; 2000 Dec 15; 35(4):981-91. PubMed ID: 11072283
    [Abstract] [Full Text] [Related]

  • 10. [Indications for surgical treatment and medical treatment of atherosclerosis].
    Paredero Del Bosque Martin V.
    Minerva Med; 1980 Oct 20; 71(40):2963-7. PubMed ID: 7454082
    [No Abstract] [Full Text] [Related]

  • 11. [The significance of sulodexide in the prevention of obliterative atherosclerotic arterial disease of the lower limbs].
    Martino R, Benini D.
    Clin Ter; 1985 Mar 15; 112(5):429-37. PubMed ID: 4017468
    [No Abstract] [Full Text] [Related]

  • 12. Prevention and treatment of arteriosclerosis.
    DePalma RG.
    Compr Ther; 1992 Feb 15; 18(2):30-2. PubMed ID: 1547601
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
    Utratová J, Mayer J, Elbl L, Vorlícek J, Prásek J.
    Vnitr Lek; 1993 Jun 15; 39(6):575-80. PubMed ID: 8212613
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness of short-term sulodexide treatment on peripheral vascular disease clinical manifestations.
    Caramelli L, Mirchioni R, Carini A.
    Riv Eur Sci Med Farmacol; 1988 Feb 15; 10(1):55-8. PubMed ID: 3079198
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of coronary arteriosclerosis depending on the nature of lipid metabolism disorders].
    Anisimov VE, Semavin IE.
    Klin Med (Mosk); 1975 Jul 15; 53(7):66-9. PubMed ID: 1206996
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Editorial on CHD.
    Riesen WF.
    J Cardiovasc Pharmacol; 1995 Jul 15; 25 Suppl 4():S1-2. PubMed ID: 9044998
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.